Giuseppe Benagiano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giuseppe Benagiano has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Maurizio Mori
3 shared publicationsGedis Grudzinskas
2 shared publicationsA Lalonde
Executive Vice‐President, Society of Gynecologists and Obstetricians of Canada, and Manager, the FIGO Save the Mothers Initiative
1 shared publicationB Thomas
Administrative Director, FIGO, UK
1 shared publicationFrancesco Maria Primiero
Department of Gynaecological Sciences, Perinatology, and Perinatal Care, University “La Sapienza,” Roma, Italy
1 shared publicationIvo Brosens
1 shared publication
Latest Publications
- 30 June 2011
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 22 (7) , 692-700
Early pregnancy wastage: ethical considerations
- 30 June 2011
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 22 (7) , 692-700
Early pregnancy wastage: ethical considerations
- 1 June 2011
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 22 (7) , 701-709
Condoms, HIV and the Roman Catholic Church
- 1 June 2011
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 22 (7) , 701-709
Condoms, HIV and the Roman Catholic Church
- 1 December 2010
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 21 (6) , 732-741
Fate of fertilized human oocytes
- 1 December 2010
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 21 (6) , 732-741
Fate of fertilized human oocytes
- 1 March 2010
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 20 (3) , 398-402
The Italian Constitutional Court modifies Italian legislation on assisted reproduction technology
- 1 March 2010
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 20 (3) , 398-402
The Italian Constitutional Court modifies Italian legislation on assisted reproduction technology
- 1 January 2009
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 18, 50-59
The origins of human sexuality: procreation or recreation?
- 1 January 2009
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 18, 50-59
The origins of human sexuality: procreation or recreation?
- 31 December 2007
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 14, 162-168
Evolution of thinking of the Catholic Church on the beginning of human life
- 31 December 2007
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 14, 162-168
Evolution of thinking of the Catholic Church on the beginning of human life
- 30 July 2004
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 86 (2) , 283-293
The FIGO Save the Mothers Initiative
- 30 July 2004
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 86 (2) , 283-293
The FIGO Save the Mothers Initiative
- 1 November 2003
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 997 (1) , 163-173
Seventy‐Five Microgram Desogestrel Minipill, A New Perspective in Estrogen‐Free Contraception
Abstract: Progestin‐only minipills have been available for over three decades, yet their use has been limited, because of a documented lower efficacy when compared to pills that combine estrogen and progestin. The availability of a new low‐dose progestin‐only minipill containing 75 μg desogestrel (DSG) offers a new perspective, since, in a large multicenter study, this minipill gave a crude Pearl index of 0.41 and an adjusted one of 0.14, which is comparable to indicies found in clinical trials of oral contraceptives. This minipill also allows for a 12‐hour tolerance time in taking the pill. The high effectiveness of the DSG minipill is attributable to an almost constant inhibition of ovulation, as shown by the absence of elevated progesterone circulating levels and inhibition of follicular growth in the vast majority of cycles studied. Since irregular bleeding patterns are observed with all minipills, patterns experienced with DSG 75 μg have been compared to those obtained with levonogestrel 30 μg. As expected, the more pronounced ovarian inhibition produced wider bleeding variability with DSG, but also less bleeding overall. The DSG minipill is suitable for lactating women and represents a valuable addition to oral contraception.
- 1 November 2003
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 997 (1) , 163-173
Seventy‐Five Microgram Desogestrel Minipill, A New Perspective in Estrogen‐Free Contraception
Abstract: Progestin‐only minipills have been available for over three decades, yet their use has been limited, because of a documented lower efficacy when compared to pills that combine estrogen and progestin. The availability of a new low‐dose progestin‐only minipill containing 75 μg desogestrel (DSG) offers a new perspective, since, in a large multicenter study, this minipill gave a crude Pearl index of 0.41 and an adjusted one of 0.14, which is comparable to indicies found in clinical trials of oral contraceptives. This minipill also allows for a 12‐hour tolerance time in taking the pill. The high effectiveness of the DSG minipill is attributable to an almost constant inhibition of ovulation, as shown by the absence of elevated progesterone circulating levels and inhibition of follicular growth in the vast majority of cycles studied. Since irregular bleeding patterns are observed with all minipills, patterns experienced with DSG 75 μg have been compared to those obtained with levonogestrel 30 μg. As expected, the more pronounced ovarian inhibition produced wider bleeding variability with DSG, but also less bleeding overall. The DSG minipill is suitable for lactating women and represents a valuable addition to oral contraception.